Tempest Therapeutics Inc. (TPST)
0.78
-0.03 (-3.63%)
At close: Mar 03, 2025, 3:59 PM
0.78
0.45%
After-hours: Mar 03, 2025, 04:31 PM EST
Tempest Therapeutics Balance Sheet Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
Cash & Equivalents | 39.23M | 31.23M | 51.83M | 18.82M | 63.51M | 73.33M | 17.62M | 43.93M | 43.42M | 6.41M | 18.08M | 14.78M | 4.54M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | 4.38M | 51.5M | 70.46M | 83.44M | 53.82M | 26.35M | 16.61M | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | 439K | 146K | 504K | 439K | n/a | 1.5M | n/a | n/a |
Other Long-Term Assets | 448K | 429K | 111K | 51K | 507K | 213K | -3.19M | 23K | n/a | 327K | 88K | 93K | n/a |
Receivables | n/a | n/a | n/a | 260K | 1.28M | 2.33M | 1.03M | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | 1.58M | 686K | n/a | n/a | 1.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.13M | 1.42M | 17.13M | 745K | 8.71M | 3.37M | -48.5M | 2.06M | 3M | 1.65M | 650K | 574K | 44K |
Total Current Assets | 40.36M | 32.95M | 68.96M | 19.82M | 71.13M | 83.42M | 19.74M | 116.44M | 129.86M | 61.88M | 45.08M | 31.96M | 4.58M |
Property-Plant & Equipment | 10.79M | 12.71M | 4.16M | 2.99M | 3.33M | n/a | 3.11M | 5.57M | 8.31M | 3.37M | 880K | 756K | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 11.24M | 13.14M | 4.28M | 3.04M | 3.84M | 652K | 74K | 6.1M | 8.75M | 3.69M | 2.47M | 849K | n/a |
Total Assets | 51.6M | 46.09M | 73.24M | 22.86M | 74.97M | 84.07M | 19.81M | 122.54M | 138.61M | 65.57M | 47.55M | 32.81M | 4.58M |
Account Payables | 845K | 1.11M | 991K | 1.07M | 1.5M | 2M | 1.3M | 2.18M | 3.35M | 2.52M | 1.65M | 875K | 276K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 334K | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 5.24M | 2.83M | 2.88M | 712K | 1.99M | 189K | 174K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 3.33M | 3.34M | 16.15M | 1.44M | 9.03M | 7.63M | 2.29M | 11.03M | 7.89M | 7.65M | 4.12M | 1.21M | 399K |
Total Current Liabilities | 9.41M | 7.28M | 20.03M | 3.22M | 12.52M | 9.82M | 4.09M | 13.21M | 11.24M | 10.17M | 5.77M | 2.09M | 675K |
Long-Term Debt | 15.42M | 20.7M | 17.09M | 1.73M | 2.33M | 383K | 599K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | 86.71M | 248K | 752K | 139K | 1.12M | 520K | 73K | 70K | 7K | 87K |
Total Long-Term Liabilities | 15.42M | 20.7M | 17.09M | 88.43M | 2.58M | 1.13M | 738K | 1.12M | 520K | 73K | 70K | 7K | 87K |
Total Liabilities | 24.84M | 27.98M | 37.12M | 91.66M | 15.1M | 10.95M | 4.83M | 14.32M | 11.76M | 10.25M | 5.84M | 2.09M | 762K |
Total Debt | 20.66M | 22.11M | 18.54M | 2.44M | 4.52M | 572K | 773K | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock | 22K | 11K | 7K | 15K | 18K | 13K | 36K | 36K | 27K | 24K | 18K | 14K | 2K |
Retained Earnings | -165.26M | -135.77M | -100.06M | -71.76M | -208.65M | -164.09M | -136.89M | -250.18M | -167.92M | -94.7M | -45.18M | -16.13M | -2.62M |
Comprehensive Income | 0.00 | -0.00 | -73.24M | 452K | 165K | 148K | -19K | -60K | -170K | -1.14M | -688K | -6K | n/a |
Shareholders Equity | 26.77M | 18.11M | 36.12M | -68.79M | 58.55M | 70.95M | 2.23M | 108.22M | 126.85M | 55.33M | 41.7M | 30.72M | 3.82M |
Total Investments | 388K | n/a | n/a | n/a | n/a | 4.82M | 51.65M | 70.96M | 83.88M | 53.82M | 27.85M | 16.61M | n/a |